141 related articles for article (PubMed ID: 36266183)
1. Incidence of Pneumonitis Among Limited Stage Small Cell Lung Cancer Patients Exposed to Concurrent Chemoradiation: A Systematic Literature Review and Meta-Analysis.
Kuang Y; Singh R; Nevo A; Deitz AC; Pietanza MC; Liu A; Uyei J; Zu K
Clin Lung Cancer; 2022 Dec; 23(8):659-669. PubMed ID: 36266183
[TBL] [Abstract][Full Text] [Related]
2. Chemoradiation-induced pneumonitis in patients with unresectable stage III non-small cell lung cancer: A systematic literature review and meta-analysis.
Kuang Y; Pierce CM; Chang HC; Sosinsky AZ; Deitz AC; Keller SM; Samkari A; Uyei J
Lung Cancer; 2022 Dec; 174():174-185. PubMed ID: 35717343
[TBL] [Abstract][Full Text] [Related]
3. Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials.
Viani GA; Gouveia AG; Matsuura FK; Jacinto AA; Moraes FY
Radiother Oncol; 2022 Aug; 173():41-48. PubMed ID: 35101470
[TBL] [Abstract][Full Text] [Related]
4. No survival benefit with early incorporation of thoracic radiotherapy using daily fractionation in patients with limited-stage small cell lung cancer undergoing chemoradiotherapy in the modern era: A systematic review and meta-analysis.
Kim BH; Song C; Kim HJ
Radiother Oncol; 2023 Jul; 184():109696. PubMed ID: 37150449
[TBL] [Abstract][Full Text] [Related]
5. Pneumonitis with combined immune checkpoint inhibitors and chemoradiotherapy in locally advanced non-small-cell lung cancer: a systematic review and meta-analysis.
Yang L; Li B; Xu Y; Zou B; Fan B; Wang C; Wang L
Future Oncol; 2023 May; 19(16):1151-1160. PubMed ID: 37293787
[TBL] [Abstract][Full Text] [Related]
6. Endostar acts as a pneumonitis protectant in patients with locally advanced non-small cell lung cancer receiving concurrent chemoradiotherapy.
Chen K; Li S; Chen M; Jin Z; Sun X; Zhou S; Yang H
BMC Cancer; 2024 Feb; 24(1):257. PubMed ID: 38395838
[TBL] [Abstract][Full Text] [Related]
7. Effect of Sequence of Radiotherapy Combined With Immunotherapy on the Incidence of Pneumonitis in Patients With Lung Cancer: A Systematic Review and Network Meta-Analysis.
Mi S; Liang N; Zhang Y; Zhang Y; Wang F; Qiao L; Chen F; Hu P; Zhang J
Clin Lung Cancer; 2024 Jan; 25(1):18-28.e3. PubMed ID: 37612176
[TBL] [Abstract][Full Text] [Related]
8. Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities.
Kobayashi H; Wakuda K; Naito T; Mamesaya N; Omori S; Ono A; Kenmotsu H; Murakami H; Endo M; Harada H; Gon Y; Takahashi T
Radiat Oncol; 2021 Mar; 16(1):52. PubMed ID: 33731123
[TBL] [Abstract][Full Text] [Related]
9. Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma.
Giuliani ME; Lindsay PE; Kwan JY; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
Clin Lung Cancer; 2015 May; 16(3):216-20. PubMed ID: 25532963
[TBL] [Abstract][Full Text] [Related]
10. Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non-Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical Trial.
Bi N; Liang J; Zhou Z; Chen D; Fu Z; Yang X; Feng Q; Hui Z; Xiao Z; Lv J; Wang X; Zhang T; Wang X; Deng L; Wang W; Wang J; Liu L; Hu C; Wang L
JAMA Netw Open; 2019 Dec; 2(12):e1918070. PubMed ID: 31851351
[TBL] [Abstract][Full Text] [Related]
11. Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: Meta-analysis of 153 cohorts with 15,713 patients: Meta-analysis of incidence and risk factors of EGFR-TKI pneumonitis in NSCLC.
Suh CH; Park HS; Kim KW; Pyo J; Hatabu H; Nishino M
Lung Cancer; 2018 Sep; 123():60-69. PubMed ID: 30089596
[TBL] [Abstract][Full Text] [Related]
12. Incidence of antibody-drug conjugates-related pneumonitis in patients with solid tumors: A systematic review and meta-analysis.
Zhu Z; Shen G; Li J; Qiu T; Fang Q; Zheng Y; Xin Y; Liu Z; Zhao F; Ren D; Zhao J
Crit Rev Oncol Hematol; 2023 Apr; 184():103960. PubMed ID: 36907365
[TBL] [Abstract][Full Text] [Related]
13. Application of postoperative adjuvant radiotherapy in limited-stage small cell lung cancer: A systematic review and meta-analysis.
Zhang C; Zhao G; Wu H; Jiang J; Duan W; Fan Z; Wang Z; Wang R
Radiother Oncol; 2024 Apr; 193():110123. PubMed ID: 38309584
[TBL] [Abstract][Full Text] [Related]
14. Design and Rationale for a Phase III, Randomized, Placebo-controlled Trial of Durvalumab With or Without Tremelimumab After Concurrent Chemoradiotherapy for Patients With Limited-stage Small-cell Lung Cancer: The ADRIATIC Study.
Senan S; Okamoto I; Lee GW; Chen Y; Niho S; Mak G; Yao W; Shire N; Jiang H; Cho BC
Clin Lung Cancer; 2020 Mar; 21(2):e84-e88. PubMed ID: 31948903
[TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: A systematic review and meta-analysis.
Tan TH; Soon YY; Cheo T; Ho F; Wong LC; Tey J; Tham IWK
Radiother Oncol; 2018 Oct; 129(1):10-17. PubMed ID: 29555182
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic ablative radiotherapy in T1-2N0M0 small cell lung cancer: A systematic review and meta-analysis.
Safavi AH; Mak DY; Boldt RG; Chen H; Louie AV
Lung Cancer; 2021 Oct; 160():179-186. PubMed ID: 34330566
[TBL] [Abstract][Full Text] [Related]
18. [Phase I Study of Etoposide and Cisplatin Chemotherapy Dose Escalation
with Concurrent Twice-daily Radiotherapy for Patients
with Limited-stage Small Cell Lung Cancer].
You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G
Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):55-60. PubMed ID: 28103974
[TBL] [Abstract][Full Text] [Related]
19. Risk of Pneumonitis Associated with Programmed Cell Death 1 Inhibitors in Cancer Patients: A Meta-analysis.
Zhang S; Liang F; Zhu J; Chen Q
Mol Cancer Ther; 2017 Aug; 16(8):1588-1595. PubMed ID: 28446641
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of PD-1/PD-L1 inhibitors combined with radiotherapy in patients with non-small-cell lung cancer: a systematic review and meta-analysis.
Geng Y; Zhang Q; Feng S; Li C; Wang L; Zhao X; Yang Z; Li Z; Luo H; Liu R; Lu B; Wang X
Cancer Med; 2021 Feb; 10(4):1222-1239. PubMed ID: 33465302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
